Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Postdoctoral Research Associate in Translational Biology (175149)

Closing date: 30 September 2024

Botnar Research scientists

The Oxford Translational Myeloma Centre is looking for a highly qualified and dedicated Postdoctoral Research Associate in Translational Biology.

Project Administrator (175516)

Closing date: 3 October 2024

Kadoorie NDORMS Professional services

As a Project Administrator, you will carry out day-to-day administrative coordination of project(s) with minimum supervision, reporting problems immediately, and providing updates to the Trial Manager.

Postdoctoral Research Associate in Computational Single-Cell Analysis (175446)

Closing date: 3 October 2024

Botnar Research delivery

Be part of a team delivering biologically-informed computational analysis of single-cell resolution datasets of soft and hard musculoskeletal tissues.

Medical Statistician (175205)

Closing date: 7 October 2024

Botnar NDORMS Research delivery

A varied and interesting role we are looking for someone to help with: the development and validation of prediction models, carrying out systematic reviews, cleaning/linking large data sets, and clinical trial development.

Postdoctoral Researcher in Cell Assay Development and chemico-genomic Screening (175200)

Closing date: 9 October 2024

Botnar NDORMS Research delivery

With demonstrable experience in molecular and cell biology techniques your role will be the development and adaptation of cell-based assays, execution of chemical and genetic screening and identification of mode of action of identified hits that could constitute novel targets in MSK diseases.